SCHEMBL27588588

SCHEMBL27588588

CN(C)Cc1cccc(C2=CC=N[N]2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 2/20 0.46
▸ ATP4A P20648 2/20 0.40
▸ ATP4B P51164 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TAAR1 Q96RJ0 2/20 0.40
▸ NOS1 P29475 1/20 0.39
▸ PARP1 P09874 4/20 0.38
▸ S1PR1 P21453 1/20 0.38
▸ CHRNB2 P17787 1/20 0.38
▸ CHRNA4 P43681 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.36
▸ AOC3 Q16853 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ AURKA O14965 1/20 0.34
▸ AURKB Q96GD4 1/20 0.34
▸ INCENP Q9NQS7 1/20 0.34
▸ TPX2 Q9ULW0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27606414 0.80 HRH3 (0.55) ALDH1A1TSHRTAAR1NOS1PARP1
SCHEMBL27588484 0.79 CDK8 (0.42) TAAR1NOS1HRH3
SCHEMBL27606407 0.75 ALDH1A1 (0.40) HTR7ATP4AATP4BALDH1A1TSHR
SCHEMBL3464184 0.72 TAAR1 (0.67) HTR7ALDH1A1TSHRTAAR1NOS1
SCHEMBL29864624 0.72 TAAR1 (0.67) HTR7ALDH1A1TSHRTAAR1NOS1
SCHEMBL989636 0.71 ALDH1A1 (0.67) HTR7ALDH1A1TSHRTAAR1NOS1
SCHEMBL20031290 0.70 PRKCI (0.61) HTR7ATP4AATP4BALDH1A1TSHR
SCHEMBL27606266 0.69 MAOA (0.47) ALDH1A1TSHRHPGD
SCHEMBL27588599 0.69 DYRK1A (0.50) —
SCHEMBL3140283 0.67 TAAR1 (0.51) HTR7ATP4AATP4BALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 — — CN disclosed
Send feedback